Effects of multi-mode physical stimulation on APP/PS1 Alzheimer's disease model mice

Heliyon - Tập 8 - Trang e12366 - 2022
Shupeng Liu1, Shuyang Li1, Yudan Xia1, Heng Zhang1, Jing Tian2, Chunlei Shan3, Fufei Pang1, Ying Wang4, Yana Shang1, Na Chen1
1Key Laboratory of Specialty Fiber Optics and Optical Access Networks, Shanghai Institute for Advanced Communication and Data Science, Shanghai University, Shanghai 200444, China
2School of Electron and Computer, Southeast University Chengxian College, Nanjing, 210088, China
3School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
4School of Public Health, Fudan University, Shanghai 200032, China

Tài liệu tham khảo

Abulizi, 2015, Effect of electro-acupuncture intervention on hippocampus Aβ stain and ultrastructure in APP/PS1 double transgenic rats, Global Traditional Chinese Medicine, 8, 518 Anders, 2015, Low-level light/laser therapy versus photobiomodulation therapy, Photomed Laser Surg, 33, 183, 10.1089/pho.2015.9848 Beyreuther, 1991, Amyloid precursor protein (APP) and ΒZA4 amyloid in the etiology of Alzheimer’s disease: precursor-product relationships in the derangement of neuronal function, Brain Pathol., 1, 241, 10.1111/j.1750-3639.1991.tb00667.x Boggio, 2011, Non-invasive brain stimulation to assess and modulate neuroplasticity in Alzheimer’s disease, Neuropsychol. Rehabil., 21, 703, 10.1080/09602011.2011.617943 Castellano, 2012, Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis, P Natl Acad Sci USA, 109, 15502, 10.1073/pnas.1206446109 Chan, 2013, Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis, Lancet, 381, 2016, 10.1016/S0140-6736(13)60221-4 Cheignon, 2018, Oxidative stress and the amyloid-beta peptide in Alzheimer’s disease, Redox Biol., 14, 450, 10.1016/j.redox.2017.10.014 Chiavellini, 2022, Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders, Neural Regen Res, 17, 469, 10.4103/1673-5374.320966 Crews, 2010, Molecular mechanisms of neurodegeneration in Alzheimer’s disease, Hum. Mol. Genet., 19, 1, 10.1093/hmg/ddq160 Di Loreto, 2014, Regular and moderate exercise initiated in middle age prevents age-related amyloidogenesis and preserves synaptic and neuroprotective signaling in mouse brain cortex, Exp. Gerontol., 57, 57, 10.1016/j.exger.2014.05.006 D’Hooge, 2001, Applications of the Morris water maze in the study of learning and memory, Brain Res. Rev., 36, 60, 10.1016/S0165-0173(01)00067-4 Fonseca, 2019, A fingerprint of amyloid plaques in a bitransgenic animal model of Alzheimer’s disease obtained by statistical unmixing analysis of hyperspectral Raman data, Analyst, 144, 7049, 10.1039/C9AN01631G Fulop, 2022, Immunosenescence and Alzheimer’s disease, Healthy Ageing and Longevity, 16, 177, 10.1007/978-3-030-87532-9_9 Guo, 2020, Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease, Mol. Neurodegener., 15, 1, 10.1186/s13024-020-00391-7 Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide, Nat. Rev. Mol. Cell Biol, 8, 101, 10.1038/nrm2101 Hamblin, 2016, 2016. Shining light on the head: photobiomodulation for brain disorders, BBA Clinical, 6, 113, 10.1016/j.bbacli.2016.09.002 Hampel, 2020, A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer’s disease, Front. Immunol, 11, 1, 10.3389/fimmu.2020.00456 Holtzman, 2011, Alzheimer’s disease: the challenge of the second century, Sci Transl Med, 3, 1, 10.1126/scitranslmed.3002369 Hu, 2020, Effects of electrical stimulation on cell activity, cell cycle, cell apoptosis and β-catenin pathway in the injured dorsal root ganglion cell, Molecular Med. Rep., 21, 2385 Huang, 2020, Clinical trials of new drugs for Alzheimer disease, J. Biomed. Sci., 27, 1, 10.1186/s12929-019-0609-7 Huang, 2021, The cerebral changes induced by exercise interventions in people with mild cognitive impairment and Alzheimer’s disease: a systematic review, Arch Gerontol Geriatr, 98, 1 Iaccarino, 2016, Gamma frequency entrainment attenuates amyloid load and modifies microglia, Nature, 540, 230, 10.1038/nature20587 Jack, 2018, NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease, Alzheimer’s and Dementia, 14, 535, 10.1016/j.jalz.2018.02.018 Ju, 2022, Pathological mechanisms and therapeutic strategies for Alzheimer’s disease, Neural Regen Res, 17, 543, 10.4103/1673-5374.320970 Koch, 2018, Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer’s disease, Neuroimage, 169, 302, 10.1016/j.neuroimage.2017.12.048 Koychev, 2018, Aβ42/Aβ40 and Aβ42/Aβ38 ratios are associated with measures of gait variability and activities of daily living in mild Alzheimer’s disease: a pilot study, Int J Alzheimers Dis, 65, 1377, 10.3233/JAD-180622 Kudlicka, 2019, Cognitive rehabilitation for people with mild to moderate dementia, Cochrane Database Syst. Rev., 3, 1 Lai, 2020, The comparative efficacy of multiple interventions for mild cognitive Impairment in Alzheimer’s Disease, A Bayesian Network Meta-Analysis, 12, 1 Lamb, 2018, Aerobic and strength training exercise program for cognitive impairment in people with mild to moderate dementia: the DAPA RCT, Health Technol Assess (Rockv), 22, 1, 10.3310/hta22280 Lane, 2018, Alzheimer’s disease, Eur J Neurol, 25, 59, 10.1111/ene.13439 Lee, 2013, An update of animal models of Alzheimer disease with a reevaluation of plaque depositions, Exp Neurobiol, 22, 84, 10.5607/en.2013.22.2.84 Li, 2020, Insights into lncRNAs in Alzheimer’s disease mechanisms, RNA Biol, 18, 1 Li, 2012, Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer’s disease, Adv. Mater, 24, 1722, 10.1002/adma.201104864 Long, 2019, Alzheimer disease: an update on pathobiology and treatment strategies, Cell, 179, 312, 10.1016/j.cell.2019.09.001 Manca, 2019, Amyloid PETs are commonly negative in suspected Alzheimer’s disease with an increase in CSF phosphorylated-tau protein concentration but an Aβ42 concentration in the very high range: a prospective study, J. Neurol., 266, 1685 Martorell, 2019, Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition, Cell, 177, 256, 10.1016/j.cell.2019.02.014 Merino-Serrais, 2019, 27-Hydroxycholesterol induces aberrant morphology and synaptic dysfunction in hippocampal neurons, Cereb. Cortex, 29, 429, 10.1093/cercor/bhy274 Molinuevo, 2020, Emerging beta-amyloid pathology is associated with tau, synaptic, neurodegeneration and gray matter volume differences, Alzheimers Dement, 16, 1, 10.1002/alz.044466 Pang, 2021, Repetitive transcranial magnetic stimulation improves mild cognitive impairment associated with Alzheimer's disease in mice by modulating the mir-567/neurod2/psd95 axis, Neuropsychiatr Dis Treat, 17, 2151, 10.2147/NDT.S311183 Pei, 2019, Effects of electroacupuncture at Baihui and Yongquan on LC3 in brains in four-month-old APP/PS1 transgenic mice, World Sci. Technol. Modernization Traditional Chin. Med., 21, 307 Pickering, 2021, Pharmaceutical research, 2021. Cognitive deficits in type-1 diabetes: aspects of glucose, cerebrovascular and amyloid involvement, Pharm. Res., 38, 1477, 10.1007/s11095-021-03100-1 Tyan, 2012, Amyloid precursor protein (APP) regulates synaptic structure and function, Mol. Cell. Neurosci, 51, 43, 10.1016/j.mcn.2012.07.009 Vorhees, 2010, Morris water maze: procedures for assessing spatial and related forms of learning and memory, Neurology, 1, 848 Waragai, 2012, Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer’s disease, Int. J. Alzheimers Dis., 32, 33, 10.3233/JAD-2012-120253 Wegmann, 2021, The Authors, A current view on Tau protein phosphorylation in Alzheimer’s disease, Curr. Opin. Neurobiol, 69, 131, 10.1016/j.conb.2021.03.003 Xie, 2021, Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by d -galactose and Aβ 1– 40 injection in ovariectomized Alzheimer’s disease model rats, Pharm Biol, 59, 1402, 10.1080/13880209.2021.1990353 Zibrandtsen, 2020, Gamma entrainment in a large retrospective cohort: implications for photic stimulation therapy for Alzheimer’s disease, J. Alzheimer's Disease, 75, 1181, 10.3233/JAD-200083 Zhang, 2017, Sepsis-induced selective loss of NMDA receptors modulates hippocampal neuropathology in surviving septic mice, PLoS ONE, 12, 1 Zhang, 2015, Cognitive improvement by photic stimulation in a mouse model of Alzheimer’s disease, Curr Alzheimer Res, 12, 860, 10.2174/1567205012666150710115755 Zhang, 2021, Blockade of the NLRP3/caspase-1 axis attenuates ketamine-induced hippocampus pyroptosis and cognitive impairment in neonatal rats, J. Neuroinflammation, 18, 1, 10.1186/s12974-021-02295-9